pharmaphorum |
AZ to file potential blockbuster potassium drug in Asia
pharmaphorum AstraZeneca is planning filings of its high potassium drug Lokelma in Asia, following supportive trial findings. The company made the announcement as it presented findings of the phase III HARMONIZE Global trial, which tested the drug in patients with ... |
Friday, 26 October 2018
AZ to file potential blockbuster potassium drug in Asia - pharmaphorum
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment